MetaCap

Monopar Therapeutics (MNPR) News

NASDAQ: MNPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

69.00-1.29 (-1.84%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MNPR news summary

We found 3 recent headlines mentioning Monopar Therapeutics (MNPR): 0 in the past week and 3 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, MNPR is down 1.84% at $69.00. The most recent story, "Monopar Therapeutics Inc. Reports Third Quarter 2026 Financial Results and Progresses ALXN1840 NDA Submission", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Monopar Therapeutics headlines

Compare MNPR